Lv2
104 积分 2024-09-06 加入
Chimeric antigen receptor T cells in treatment-refractory DAGLA antibody-associated encephalitis
5天前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
13天前
已完结
Idiopathic inflammatory myopathies
14天前
已完结
Advances in the classification and management of idiopathic inflammatory myopathies
14天前
已完结
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
20天前
已完结
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
20天前
已完结
CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemia
22天前
已完结
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study
26天前
已完结
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies
26天前
已关闭
Immunopathogenic mechanisms of systemic autoimmune disease
29天前
已完结
皖公网安备34019202002308
